Introduction of a new paediatric asthma guideline: Effects on asthma control levels

S C Hammer1, L J H Sonneveld1, K D G van de Kant1

  • 1Department of Paediatric Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.

Insights

A new paediatric asthma guideline did not improve overall asthma control in children. While step-down treatment increased for controlled asthma, uncontrolled asthma management remained unchanged.

Area of Science:

  • Pediatric Pulmonology
  • Public Health Guidelines
  • Asthma Management

Background:

  • A national paediatric asthma management guideline, based on the Global Initiative for Asthma (GINA), was implemented in the Netherlands in 2008.
  • This study aimed to evaluate the impact of this guideline on asthma control and treatment strategies in children.

Purpose of the Study:

  • To assess whether the introduction of a new national paediatric asthma management guideline improved asthma control and treatment regimens.
  • To compare asthma control and treatment patterns before and after the guideline's implementation.

Main Methods:

  • A comparative study involving two groups of children (6-16 years) with asthma, surveyed in 2004 (before) and 2013 (after) the guideline introduction.
  • Data collection included questionnaires for children, parents, and paediatricians on symptoms, medication, and healthcare use, supplemented by spirometry.

Main Results:

  • Asthma control levels did not significantly improve; the proportion of controlled asthmatics was 51% in 2004 and 59% in 2013 (p=0.28).
  • Paediatricians' assessment of control (76%) differed from GINA criteria (59%) in 2013 (p<0.05).
  • Step-down treatment for controlled asthma increased significantly (8% to 40%, p<0.05), but step-up treatment for uncontrolled asthma did not improve.

Conclusions:

  • The new paediatric asthma guideline did not lead to an improvement in overall asthma control.
  • An improvement was noted in the application of step-down treatment for children with controlled asthma following the guideline's introduction.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.1K